Literature DB >> 11846033

Molecular pathology and pathobiology of osteoarthritic cartilage.

T Aigner1, L McKenna.   

Abstract

The biochemical properties of articular cartilage rely on the biochemical composition and integrity of its extracellular matrix. This matrix consists mainly of a collagen network and the proteoglycan-rich ground substance. In osteoarthritis, ongoing cartilage matrix destruction takes place, leading to a progressive loss in joint function. Beside the degradation of molecular matrix components, destabilization of supramolecular structures such as the collagen network and changes in the expression profile of matrix molecules also take place. These processes, as well as the pattern of cellular reaction, explain the pathology of osteoarthritic cartilage degeneration. The loss of histochemical proteoglycan staining reflects the damage at the molecular level, whereas the supramolecular matrix destruction leads to fissuring and finally to the loss of the cartilage. Chondrocytes react by increasing matrix synthesis, proliferating, and changing their cellular phenotype. Gene expression mapping in situ and gene expression profiling allows characterization of the osteoarthritic cellular phenotype, a key determinant for understanding and manipulating the osteoarthritic disease process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846033     DOI: 10.1007/s00018-002-8400-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  73 in total

Review 1.  Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?

Authors:  K E Rhodes; J W Fawcett
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

2.  Progression analysis and stage discovery in continuous physiological processes using image computing.

Authors:  Lior Shamir; Salim Rahimi; Nikita Orlov; Luigi Ferrucci; Ilya G Goldberg
Journal:  EURASIP J Bioinform Syst Biol       Date:  2010-06-30

3.  Intra-articular delivery of anti-Hif-2α siRNA by chondrocyte-homing nanoparticles to prevent cartilage degeneration in arthritic mice.

Authors:  Y Pi; X Zhang; Z Shao; F Zhao; X Hu; Y Ao
Journal:  Gene Ther       Date:  2015-04-16       Impact factor: 5.250

4.  MiRNA-140 is a negative feedback regulator of MMP-13 in IL-1β-stimulated human articular chondrocyte C28/I2 cells.

Authors:  Zu-Jian Liang; Hong Zhuang; Guo-Xia Wang; Zhao Li; Huan-Tian Zhang; Tian-Qi Yu; Bai-Dang Zhang
Journal:  Inflamm Res       Date:  2012-01-25       Impact factor: 4.575

5.  Osteoarthritis severity of the hip by computer-aided grading of radiographic images.

Authors:  I Boniatis; L Costaridou; D Cavouras; I Kalatzis; E Panagiotopoulos; G Panayiotakis
Journal:  Med Biol Eng Comput       Date:  2006-08-15       Impact factor: 2.602

6.  [Histopathological examination of joint degeneration: typing, grading and staging of osteoarthritis].

Authors:  T Aigner; S Söder
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

Review 7.  [Osteoarthritis. Etiology, typing, staging and histological grading].

Authors:  S Söder; T Aigner
Journal:  Pathologe       Date:  2011-05       Impact factor: 1.011

Review 8.  [Osteoarthritis--histopathologic diagnosis: typing, grading, and staging].

Authors:  J Zustin; T Aigner
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

9.  The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease.

Authors:  Ian D Welch; Matthew F Cowan; Frank Beier; Tully M Underhill
Journal:  Arthritis Res Ther       Date:  2009-01-28       Impact factor: 5.156

10.  p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation.

Authors:  Lee-Anne Stanton; Shalev Sabari; Arthur V Sampaio; T Michael Underhill; Frank Beier
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.